Biomarkers for monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma

Basic Information

Funding Cycle : 2022-2023
Name : Florentin Späth
Type of Award : Career Development Award
Home Institution : Umeå University, Sweden
Host Institution : University of Adelaide, Australia


In this collaborative research project, we aim to identify and develop blood biomarkers improving MGUS follow-up. To achieve this, blood-based proteomic analysis using untargeted i3-D/LC mass spectrometry in unique prospective longitudinal blood samples (n=880) collected in participants of the Northern Sweden Health and Disease Study (Umeå University, Sweden) is performed. Routine and novel biomarkers will be included in a novel risk score that could help to improve the stratification of MGUS patients.

Why Become a Member

The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.

The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.

Stay updated on our Events